ArticleExperimental hematology & oncology2018

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.

Henrik Gregersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.